BlackRock’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$306K Sell
449,162
-186,041
-29% -$127K ﹤0.01% 4495
2025
Q1
$579K Sell
635,203
-3,749
-0.6% -$3.42K ﹤0.01% 4314
2024
Q4
$696K Buy
638,952
+67,977
+12% +$74.1K ﹤0.01% 4275
2024
Q3
$432K Sell
570,975
-185,761
-25% -$141K ﹤0.01% 4313
2024
Q2
$938K Sell
756,736
-1,487,367
-66% -$1.84M ﹤0.01% 4145
2024
Q1
$4.24M Sell
2,244,103
-94,662
-4% -$179K ﹤0.01% 3683
2023
Q4
$6.17M Buy
2,338,765
+209,815
+10% +$554K ﹤0.01% 3533
2023
Q3
$4.9M Buy
2,128,950
+62,876
+3% +$145K ﹤0.01% 3609
2023
Q2
$7.54M Buy
2,066,074
+1,401,648
+211% +$5.12M ﹤0.01% 3477
2023
Q1
$2.37M Sell
664,426
-37,755
-5% -$135K ﹤0.01% 3894
2022
Q4
$2M Sell
702,181
-76,527
-10% -$218K ﹤0.01% 4057
2022
Q3
$1.74M Sell
778,708
-53,217
-6% -$119K ﹤0.01% 4174
2022
Q2
$2.07M Sell
831,925
-1,549,342
-65% -$3.86M ﹤0.01% 4155
2022
Q1
$11.6M Buy
2,381,267
+90,998
+4% +$444K ﹤0.01% 3422
2021
Q4
$25.9M Buy
2,290,269
+129,811
+6% +$1.47M ﹤0.01% 3070
2021
Q3
$31.5M Buy
2,160,458
+11,660
+0.5% +$170K ﹤0.01% 2931
2021
Q2
$25M Sell
2,148,798
-98,906
-4% -$1.15M ﹤0.01% 3109
2021
Q1
$27.4M Buy
2,247,704
+84,726
+4% +$1.03M ﹤0.01% 2959
2020
Q4
$27.1M Buy
2,162,978
+47,333
+2% +$592K ﹤0.01% 2789
2020
Q3
$31.8M Buy
2,115,645
+183,889
+10% +$2.77M ﹤0.01% 2518
2020
Q2
$47.3M Buy
1,931,756
+602,328
+45% +$14.8M ﹤0.01% 2255
2020
Q1
$18.9M Sell
1,329,428
-58,241
-4% -$826K ﹤0.01% 2598
2019
Q4
$22M Buy
1,387,669
+166,399
+14% +$2.64M ﹤0.01% 2787
2019
Q3
$10.3M Buy
1,221,270
+73,144
+6% +$617K ﹤0.01% 3160
2019
Q2
$10.3M Buy
1,148,126
+201,986
+21% +$1.82M ﹤0.01% 3204
2019
Q1
$7.31M Buy
946,140
+43,234
+5% +$334K ﹤0.01% 3227
2018
Q4
$4.24M Sell
902,906
-5,606
-0.6% -$26.3K ﹤0.01% 3420
2018
Q3
$8.22M Buy
908,512
+26,553
+3% +$240K ﹤0.01% 3295
2018
Q2
$10.5M Buy
881,959
+487,132
+123% +$5.78M ﹤0.01% 3191
2018
Q1
$5.55M Buy
+394,827
New +$5.55M ﹤0.01% 3351